Related references
Note: Only part of the references are listed.Dopamine receptor modulation of repetitive grooming actions in the rat: Potential relevance for Tourette syndrome
Jennifer L. Taylor et al.
BRAIN RESEARCH (2010)
Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease
Dirk W. Luchtman et al.
PHYSIOLOGY & BEHAVIOR (2009)
Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice
Rebecca Banerjee et al.
PLOS ONE (2008)
Modeling PD pathogenesis in mice: Advantages of a chronic MPTP protocol
Gloria E. Meredith et al.
PARKINSONISM & RELATED DISORDERS (2008)
Systemic proteasomal inhibitor exposure enhances dopamine turnover and decreases dopamine levels but does not affect MPTP-induced striatal dopamine depletion in mice
Sarah J. Hirst et al.
SYNAPSE (2008)
Increased host neuronal survival and motor function in BMT parkinsonian mice: Involvement of immunosuppression
Gilmor I. Keshet et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury
Giselle M. Petzinger et al.
JOURNAL OF NEUROSCIENCE (2007)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Gloria E. Meredith et al.
MOVEMENT DISORDERS (2006)
Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's
KC Berridge et al.
BMC BIOLOGY (2005)
Basal ganglia neural mechanisms of natural movement sequences
JW Aldridge et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2004)
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
EJ Benner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism
JL Tillerson et al.
JOURNAL OF NEUROSCIENCE METHODS (2003)
Behavioral changes are not directly related to striatal monoamme levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice
E Rousselet et al.
NEUROBIOLOGY OF DISEASE (2003)
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
JL Tillerson et al.
EXPERIMENTAL NEUROLOGY (2002)
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety
S Przedborski et al.
JOURNAL OF NEUROCHEMISTRY (2001)
MPTP susceptibility in the mouse: Behavioral, neurochemical, and histological analysis of gender and strain differences
M Sedelis et al.
BEHAVIOR GENETICS (2000)
Share Paper
